CClinicalTrials.gg
CompletedNCT01053637Updated Aug 25, 2021Results posted

Pain and Anxiety Management With Oral Narcotic for Pediatric Suture Repair

An interventional study of hydrocodone/acetaminophen and Sugar water in Children, Lacerations and Procedures, sponsored by Baylor College of Medicine. Completed at 1 site in United States. Open to participants aged 2 Years to 17 Years. Per ClinicalTrials.gov, last updated 2021-08-25.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Randomized
Ages
2 Years to 17 Years
Sex
All
01

Study summary

The purpose of this study is:

  • To determine whether oral narcotic medication versus placebo improves the pain and anxiety scores for pediatric patients requiring laceration repair in the pediatric emergency department and receiving the standard of care with lidocaine treatment
  • To evaluate for a statistical difference in pain scores in children during laceration repair
  • To evaluate for a statistical difference in State-Trait Anxiety Inventory for Children (STAIC) scores during laceration repair
Read the detailed description

A prospective, double-blind, placebo-controlled, randomized clinical trial in a tertiary care pediatric emergency department with an annual census of 80,000 visits per year. Patients will be randomized by a randomization table with block randomization in the pharmacy to the oral narcotic or placebo group, and the pharmacist will be the only person aware of the randomization status of the patient. Allocation concealment will be ensured by opaque, sealed envelopes kept in the Emergency Department Pharmacy. Guardians of patients age 2 to 17 years of age will be consented for enrollment.

02

Conditions studied

  • Children
  • Lacerations
  • Procedures
  • Child
  • Pain

Browse trials for

Keywords

  • lacerations
  • sutures
  • pediatrics
  • child
  • pain
  • Anxiety
03

In context

Lacerations

133 studies on the registry are indexed under Lacerations; 29 are open to participants now.

This study's enrollment of 85 is close to the median of 79 across 106 interventional studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 734 studies on the registry; 110 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 44 (53%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 2 to 17 years
  • Laceration of the skin and/or subcutaneous tissue requiring sutures
  • American Society of Anesthesiologists (ASA) score of I or II

Exclusion criteria

Exclusion Criteria:

  • Major injuries in addition to laceration (suspected fracture, intracranial, intrathoracic, or intraabdominal bleeding or organ injury)
  • Abnormal neurologic examination (such as head injury)
  • Severe congenital heart disease
  • Pregnancy
  • Known opiate or acetaminophen allergy
  • Require conscious sedation
  • Have had narcotic or acetaminophen administration within 4 previous hours
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
85 participants (actual)

Study arms

  • Experimental
    Hydrocodone/acetaminophen

    Patients will receive 0.17 mg/kg hydrocodone component to a max of 10 mg hydrocodone.

    Drug: hydrocodone/acetaminophen

  • Placebo comparator
    Sugar water

    Placebo

    Drug: Sugar water

Interventions

  • Drughydrocodone/acetaminophen

    0.17 mg/kg hydrocodone component to max of 10 mg. If dose is vomited within 5 minutes, second dose may be administered.

    Also known as: Lortab, Vicodin

  • DrugSugar water

    An equal volume of sugar water will be dispensed, as for the weight based 0.17 mg/kg hydrocodone solution given for the study drug

06

What researchers measure

Primary outcomes

  1. Statistical Difference in Pain Scores in Children During Laceration Repair Between Study and Placebo Group

    Children's Hospital of Eastern Ontario Pain Scale, for children 2-7 years. This score ranks 6 categories: Cry, Facial expression, Verbal Response, Torso movement, Touch, and Leg movement. The scale varies by each category from 0-2 or 1-2 or 1-3; such that a minimum score is 4 (no pain) and a maximum score is 13 signifying greatest pain. This results in a 10 point scale of possible results, and is rated by an objective observer; the child life specialist at the bedside during the laceration repair. If the procedure was completed, there were no scores recorded at that time point.

    Time frame: 5 minutes

Secondary outcomes

  1. Statistical Difference in State-Trait Anxiety Inventory for Children (STAIC) Scores for Children Aged 8-17 Years During Laceration Repair and VAS Pain Scale

    State-Trait Anxiety Inventory for Children - 20 questions with 3 answer options for each question. Scores range from 20 to 60 for state and 20 to 60 for trait with 60 being the higher (more or worse) anxiety on self-assessment. The VAS pain Scale from 0-10 was included in this older population as well.

    Time frame: 1 hour approximately (survey was given pre and post procedure so from 15 minutes to 1 hour after initial survey (or 5 minutes to 45 minutes after the procedure).

  2. Visual Analog Scale (VAS) Pain Score for Children > 7 Years.

    Visual Analog Scale from 0-10 as marked on a 10 cm line. 0 no pain, 10 worst pain. A child \>7 group marks their pain on the line, and a mm measurement is made. Power based on a change in the Visual Analog Scale (VAS) for children \> 7 years. A change in pain score of 10 mm (95% Confidence Interval 7-12 mm) was considered to be clinically significant based upon a previous study.

    Time frame: 30 minutes

07

Results

Posted Aug 25, 2021

Participant flow

Participant flow — Overall Study
MilestoneHydrocodone/AcetaminophenSugar Water
Started4342
Completed4342
Not completed00

Outcome measures

PrimaryStatistical Difference in Pain Scores in Children During Laceration Repair Between Study and Placebo Group

Children's Hospital of Eastern Ontario Pain Scale, for children 2-7 years. This score ranks 6 categories: Cry, Facial expression, Verbal Response, Torso movement, Touch, and Leg movement. The scale varies by each category from 0-2 or 1-2 or 1-3; such that a minimum score is 4 (no pain) and a maximum score is 13 signifying greatest pain. This results in a 10 point scale of possible results, and is rated by an objective observer; the child life specialist at the bedside during the laceration repair. If the procedure was completed, there were no scores recorded at that time point.

Time frame:
5 minutes
Reported as:
Median · units on a scale
Statistical Difference in Pain Scores in Children During Laceration Repair Between Study and Placebo Group
units on a scaleHydrocodone/AcetaminophenSugar Water
Statistical Difference in Pain Scores in Children During Laceration Repair Between Study and Placebo Group5 (4 to 6.5)7 (5.25 to 10)
Statistical analysis
  • Hydrocodone/Acetaminophen vs Sugar Water · Fisher Exact · p = 0.05 (Pain at 5 minutes using Children's Hospital of Eastern Ontario Pain Scale validated in the younger population. Using a 2-point difference in CHEOPS pain scale as a clinically significant change, 34 patients were required in the younger 2- to 7 group.)
SecondaryStatistical Difference in State-Trait Anxiety Inventory for Children (STAIC) Scores for Children Aged 8-17 Years During Laceration Repair and VAS Pain Scale

State-Trait Anxiety Inventory for Children - 20 questions with 3 answer options for each question. Scores range from 20 to 60 for state and 20 to 60 for trait with 60 being the higher (more or worse) anxiety on self-assessment. The VAS pain Scale from 0-10 was included in this older population as well.

Time frame:
1 hour approximately (survey was given pre and post procedure so from 15 minutes to 1 hour after initial survey (or 5 minutes to 45 minutes after the procedure).
Reported as:
Median · units on a scale
Statistical Difference in State-Trait Anxiety Inventory for Children (STAIC) Scores for Children Aged 8-17 Years During Laceration Repair and VAS Pain Scale
units on a scaleHydrocodone/AcetaminophenSugar Water
State Anxiety Pre-Test34.5 (31.0 to 40.75)38.0 (32.5 to 41.75)
State Anxiety Post-Test26.0 (24.0 to 30.0)29.0 (21.50 to 32.50)
VAS Pain Score at 5 minutes0.1 (0.0 to 4.23)0.5 (0.0 to 1.2)
Statistical analysis
  • Hydrocodone/Acetaminophen vs Sugar Water · Wilcoxon (Mann-Whitney) · p = 0.05
SecondaryVisual Analog Scale (VAS) Pain Score for Children > 7 Years.

Visual Analog Scale from 0-10 as marked on a 10 cm line. 0 no pain, 10 worst pain. A child \>7 group marks their pain on the line, and a mm measurement is made. Power based on a change in the Visual Analog Scale (VAS) for children \> 7 years. A change in pain score of 10 mm (95% Confidence Interval 7-12 mm) was considered to be clinically significant based upon a previous study.

Time frame:
30 minutes
Reported as:
Median · score on a scale
Visual Analog Scale (VAS) Pain Score for Children > 7 Years.
score on a scaleHydrocodone/AcetaminophenSugar Water
Baseline0.5 (0.0 to 5.30)0.85 (0.0 to 4.85)
5 minutes0.1 (0.0 to 4.23)0.5 (0.0 to 1.20)
10 minutes0.0 (0.0 to 2.00)0.0 (0.0 to 1.60)
15 minutes0.0 (0.0 to 3.18)0.0 (0.0 to 0.75)
Procedure Finish0.0 (0.0 to 0.0)0.0 (0.0 to 0.0)

Adverse events

Collected over Adverse events were collected from the time of enrollment through hospital discharge for the specific emergency department visit during which the patient was enrolled, and chart reviewed for return visit up to 72 hours from discharge.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Hydrocodone/Acetaminophen0/43 (0%)0/43 (0%)0/43 (0%)
Sugar Water0/42 (0%)0/42 (0%)0/42 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterventionPlaceboTotal
Median5.25 (3.75 to 6.74)4.87 (3.57 to 6.27)5.1 (3.6 to 6.5)
Sex: Female, Male
Sex: Female, Male(Participants)InterventionPlaceboTotal
Female71623
Male362662
Race/Ethnicity, Customized
Race/Ethnicity, Customized(participants)InterventionPlaceboTotal
African-American12820
Caucasian41014
Hispanic252348
Other213
Region of Enrollment
Region of Enrollment(participants)InterventionPlaceboTotal
United States434285
08

Study locations

1 site
  • Baylor College of Medicine
    Houston, Texas 77030, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01053637
Lead sponsor
Baylor College of Medicine
Responsible party
Corrie Chumpitazi (Assistant Professor, Baylor College of Medicine) — Principal investigator
First posted
Jan 21, 2010
Start date
Feb 2009
Primary completion
Jan 2012
Completion
May 2015
Results posted
Aug 25, 2021
Last update
Aug 25, 2021

Study contacts

Corrie Chumpitazi, MD
principal investigator · Texas Childrens Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion